PRESENTATION: Developing new assays for complex biologics

PRESENTATION: Developing new assays for complex biologics

Presentation

Information

Join this session as we explore the latest developments in quality control of complex biologics, including monoclonal antibodies and vaccines. Here, expert speakers will examine current techniques as well as discuss new QC assays to keep pace with rapid developments.

- Review best practice for analysis of biopharmaceuticals: what are the current standards and guidance?

- Discover key analytical techniques that can be used to determine the identity, purity, potency, and quality of complex biologics.


Agilent TechnologiesLet's bring great science to life Agilent supports scientists in 110 countries in cutting-edge life science research; patient diagnostics; and testing required to ensure the safety of water, food and pharmaceuticals. Our advanced instruments, software, consumables, and services enable our customers to produce the most accurate and reliable results as well as optimal scientific, economic, and operational outcomes. We play a role in advancing important research and testing, with our scientists creating some of the world's most leading-edge technology and our field engineers working side by side with customers to help them maximize productivity. We bring these solutions to a variety of markets, from pharma and diagnostics to applied materials and chemicals. Together with our customers, we’re bringing great science to life.

Log in